MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fsurg.2026.1865893

Медицинская библиотека · Frontiers in surgery · 2026

Preoperative frailty and tumor volume as determinants of primary management strategy and outcomes in petroclival meningioma patients.

Kashlan Rommi, Faraj Razan, Duggireddy Hithardhi, Zohdy Youssef M, Hasa Armela, Agudelo Arrieta Marian, Barrero Ruiz Estrella, Assi Jad, Rodas Alejandra, Salmeron-Moreno Karen, Maldonado Justin, Tariciotti Leonardo, Pradilla Gustavo, Garzon-Muvdi Tomas

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

We aimed to study how patient frailty, pre-operative tumor volume, and symptom burden collectively impact primary management choice, postoperative complication rates, and outcomes in the treatment of petroclival meningiomas.

METHODS

We retrospectively analyzed a cohort of 73 patients diagnosed with petroclival meningiomas at Emory Healthcare from 2000 to 2022. Frailty was quantified with the 5-item modified frailty index (mFI-5). Tumor volume was measured from pre-operative MRI with 3D Slicer. Tumor-related symptoms were clustered into five domains (visual, vestibulocochlear, sensory, motor, headache) and summed into a composite Symptom Burden Score (SBS). Primary management was categorized as surgical resection versus conservative therapy (serial imaging or radiotherapy). Multivariable logistic regression evaluated predictors of treatment selection; a second model examined 30-day postoperative complications in surgical patients. Linear mixed-effects models (LMM) tracked SBS, and domain-specific generalized linear mixed-effects models (GLMM) assessed symptom resolution at 3, 6, and 12 months, controlling for both frailty and treatment approach. Sensitivity analyses dichotomized frailty (mFI-5 = 0 vs. ≥1). Significance threshold: two-sided p < 0.05.

RESULTS

Surgically treated tumors were larger than conservatively managed lesions (median 14.3 cm3 vs. 8.9 cm3; p = 0.018), and management choice varied by frailty strata (χ 2 = 12.86, p = 0.015). In multivariable analysis, neither tumor volume (OR 1.04, 95% CI 0.97-1.11) nor mFI-5 score (OR 0.56, 95% CI 0.20-1.82) independently predicted operative selection. Thirty day complication rates increased with frailty but mFI-5 was not an independent risk factor (OR 0.51, 95% CI 0.22-1.18). Mean patient level SBS declined in both groups at 12 months (conservative -28%; surgical -8%), with a marginally significant interaction between treatment approach and frailty (p = 0.072). Symptom domain analysis showed significant improvement in visual and vestibulocochlear deficits irrespective of management, whereas conservative therapy was associated with poorer motor deficit recovery (p = 0.025).

CONCLUSIONS

Preoperative tumor volume and frailty jointly influence treatment approach, yet neither metric alone dictates management decision when considered together. Perioperative risk-reduction protocols may mitigate frailty-associated morbidity. While most neurologic symptoms improve within a year, frailer patients have attenuated symptomatic improvement, in addition to domain-specific differences.

Для цитирования: Kashlan Rommi, Faraj Razan, Duggireddy Hithardhi, Zohdy Youssef M, Hasa Armela, Agudelo Arrieta Marian, Barrero Ruiz Estrella, Assi Jad, Rodas Alejandra, Salmeron-Moreno Karen, Maldonado Justin, Tariciotti Leonardo, Pradilla Gustavo, Garzon-Muvdi Tomas. Preoperative frailty and tumor volume as determinants of primary management strategy and outcomes in petroclival meningioma patients.. Frontiers in surgery. 2026. DOI: 10.3389/fsurg.2026.1865893.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.